National Aug 6, 2021
Japan drugmaker Shionogi to seek approval for oral COVID-19 drug
Designed to prevent moderate COVID-19 symptoms from worsening, the drug could facilitate at-home treatment and ease the strain on hospitals.
Japan drugmaker Shionogi to seek approval for oral COVID-19 drug
Designed to prevent moderate COVID-19 symptoms from worsening, the drug could facilitate at-home treatment and ease the strain on hospitals.
Why vaccination should be compulsory
Laws requiring people to be vaccinated may be restricting one kind of freedom, but they are doing so in order to protect the freedom of others to go about their business safely.
SoftBank built a $5 billion stake in pharma giant Roche
Roche's diagnostics unit reacted swiftly to the pandemic, and now sales are boosted by its COVID-19 testing business.
The delta COVID-19 variant is tipping the pandemic into a frightening new stage and vaccination efforts are unable to keep up.
Legitimate pain research is more crucial than ever
Researchers today say opioids are not only dangerous; they are not a good long-term solution for chronic pain sufferers. The relief tends to wane with time.
Even with delta surging, experts say two vaccine doses is enough for now
U.S. firm Pfizer Inc. has called for an additional third shot of its COVID-19 vaccine, citing new data showing its efficacy tails off after six months.
How behavioral economics views mask mandates
What we know from behavioral economics suggests that universal mask requirements will undermine the effort to get as many people as possible vaccinated.
Doctors blast Biogen Alzheimer approval as ‘regulatory failure’
The New England Journal of Medicine opinion piece is another sign of persistent furor over the agency’s decision.
London’s delta surge should jolt New York
A big question is whether New York, another large city that has reopened after having been through the COVID-19 wringer in 2020, will face a similar resurgence of cases like London.
At this point, the U.K.'s COVID-19 rules follow politics as much as science
If the last 18 months have taught us anything, it’s that a successful COVID-19 policy requires three things: high levels of public trust, a coherent strategy and effective implementation.
As delta variant rages in Southeast Asia, health workers warned not to speak out
In Southeast Asian nations, health care providers calling for stronger job security and better protection against variants of the coronavirus, have put governments on the defensive.
World carved up into haves and have-nots by mRNA vaccine access
The cutting-edge technology, which made its debut during the pandemic, has proven more effective than any other in staving off infections and serious illness from the coronavirus.